These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38421735)

  • 1. Small molecules that disrupt RAD54-BLM interaction hamper tumor proliferation in colon cancer chemoresistance models.
    Kaur E; Agrawal R; Arun R; Madhavan V; Srivastava V; Kumar D; Rath PP; Kumar N; Vedagopuram S; Pandey N; Priya S; Legembre P; Gourinath S; Bajaj A; Sengupta S
    J Clin Invest; 2024 Feb; 134(8):. PubMed ID: 38421735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BLM helicase stimulates the ATPase and chromatin-remodeling activities of RAD54.
    Srivastava V; Modi P; Tripathi V; Mudgal R; De S; Sengupta S
    J Cell Sci; 2009 Sep; 122(Pt 17):3093-103. PubMed ID: 19671661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BLM has early and late functions in homologous recombination repair in mouse embryonic stem cells.
    Chu WK; Hanada K; Kanaar R; Hickson ID
    Oncogene; 2010 Aug; 29(33):4705-14. PubMed ID: 20531307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
    Sanders MA; Haynes B; Nangia-Makker P; Polin LA; Shekhar MP
    J Biol Chem; 2017 Jun; 292(25):10347-10363. PubMed ID: 28490629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity.
    Lin J; Xia L; Oyang L; Liang J; Tan S; Wu N; Yi P; Pan Q; Rao S; Han Y; Tang Y; Su M; Luo X; Yang Y; Chen X; Yang L; Zhou Y; Liao Q
    Oncogene; 2022 Feb; 41(7):1024-1039. PubMed ID: 34997215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new herbal formula BP10A exerted an antitumor effect and enhanced anticancer effect of irinotecan and oxaliplatin in the colon cancer PDTX model.
    Kim J; Kim HY; Hong S; Shin S; Kim YA; Kim NS; Bang OS
    Biomed Pharmacother; 2019 Aug; 116():108987. PubMed ID: 31112870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy.
    Tan S; Shi H; Ba M; Lin S; Tang H; Zeng X; Zhang X
    Int J Mol Med; 2016 Apr; 37(4):1030-8. PubMed ID: 26935807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin β-D-glucuronide exhibits anti-tumor effects on oxaliplatin-resistant colon cancer with less toxicity in vivo.
    Ozawa-Umeta H; Kishimoto A; Imaizumi A; Hashimoto T; Asakura T; Kakeya H; Kanai M
    Cancer Sci; 2020 May; 111(5):1785-1793. PubMed ID: 32163218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide single-nucleotide resolution of oxaliplatin-DNA adduct repair in drug-sensitive and -resistant colorectal cancer cell lines.
    Vaughn CM; Selby CP; Yang Y; Hsu DS; Sancar A
    J Biol Chem; 2020 May; 295(22):7584-7594. PubMed ID: 32299912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of N3-substituted quinazolinone derivatives as potential Bloom's Syndrome protein (BLM) helicase inhibitor for sensitization treatment of colorectal cancer.
    Tu JL; Wu BH; Wu HB; Wang JE; Zhang ZL; Gao KY; Zhang LX; Chen QR; Zhou YC; Tan JH; Huang ZS; Chen SB
    Eur J Med Chem; 2023 Jan; 246():114944. PubMed ID: 36459756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic stem cells deficient for Brca2 or Blm exhibit divergent genotoxic profiles that support opposing activities during homologous recombination.
    Marple T; Kim TM; Hasty P
    Mutat Res; 2006 Dec; 602(1-2):110-20. PubMed ID: 16997331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible association of BLM in decreasing DNA double strand breaks during DNA replication.
    Wang W; Seki M; Narita Y; Sonoda E; Takeda S; Yamada K; Masuko T; Katada T; Enomoto T
    EMBO J; 2000 Jul; 19(13):3428-35. PubMed ID: 10880455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin revert insulin-induced oxaliplatin resistance by activating mitochondrial apoptosis pathway in human colon cancer HCT116 cells.
    Liu C; Liu Q; Yan A; Chang H; Ding Y; Tao J; Qiao C
    Cancer Med; 2020 Jun; 9(11):3875-3884. PubMed ID: 32248666
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Qu J; Sun Z; Peng C; Li D; Yan W; Xu Z; Hou Y; Shen S; Chen P; Wang T
    Int J Biol Sci; 2021; 17(11):2756-2769. PubMed ID: 34345205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AURKA Increase the Chemosensitivity of Colon Cancer Cells to Oxaliplatin by Inhibiting the TP53-Mediated DNA Damage Response Genes.
    Shan B; Zhao R; Zhou J; Zhang M; Qi X; Wang T; Gong J; Wu Y; Zhu Y; Yang W; Zhang Y; Wang G; Li X
    Biomed Res Int; 2020; 2020():8916729. PubMed ID: 32851091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.
    Cross-Knorr S; Lu S; Perez K; Guevara S; Brilliant K; Pisano C; Quesenberry PJ; Resnick MB; Chatterjee D
    BMC Cancer; 2013 Oct; 13():463. PubMed ID: 24098947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitivity of resistant colon cancer cell lines to lobaplatin, heptaplatin, and dicycloplatin.
    Wei W; Liu Z; Chen X; Bi F
    Int J Clin Pharmacol Ther; 2014 Aug; 52(8):702-7. PubMed ID: 24986092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse Rad54 affects DNA conformation and DNA-damage-induced Rad51 foci formation.
    Tan TL; Essers J; Citterio E; Swagemakers SM; de Wit J; Benson FE; Hoeijmakers JH; Kanaar R
    Curr Biol; 1999 Mar; 9(6):325-8. PubMed ID: 10209103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential contributions of mammalian Rad54 paralogs to recombination, DNA damage repair, and meiosis.
    Wesoly J; Agarwal S; Sigurdsson S; Bussen W; Van Komen S; Qin J; van Steeg H; van Benthem J; Wassenaar E; Baarends WM; Ghazvini M; Tafel AA; Heath H; Galjart N; Essers J; Grootegoed JA; Arnheim N; Bezzubova O; Buerstedde JM; Sung P; Kanaar R
    Mol Cell Biol; 2006 Feb; 26(3):976-89. PubMed ID: 16428451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polarity and bypass of DNA heterology during branch migration of Holliday junctions by human RAD54, BLM, and RECQ1 proteins.
    Mazina OM; Rossi MJ; Deakyne JS; Huang F; Mazin AV
    J Biol Chem; 2012 Apr; 287(15):11820-32. PubMed ID: 22356911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.